These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 11233719)

  • 1. Generalized eczematous reaction to budesonide in a nasal spray with cross-reactivity to triamcinolone.
    Poon E; Fewings JM
    Australas J Dermatol; 2001 Feb; 42(1):36-7. PubMed ID: 11233719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-reactivity patterns to budesonide.
    Ferguson AD; Emerson RM; English JS
    Contact Dermatitis; 2002 Dec; 47(6):337-40. PubMed ID: 12581279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contact dermatitis from budesonide in a nasal spray without cross-reactivity to amcinonide.
    Gamboa PM; Jáuregui I; Antépara I
    Contact Dermatitis; 1991 Mar; 24(3):227-8. PubMed ID: 1831101
    [No Abstract]   [Full Text] [Related]  

  • 4. Exacerbation of allergic contact dermatitis from amcinonide triggered by patch testing.
    Sasseville D
    Contact Dermatitis; 2001 Oct; 45(4):232-3. PubMed ID: 11683835
    [No Abstract]   [Full Text] [Related]  

  • 5. Corticosteroid-induced contact dermatitis: a pragmatic approach.
    English JS
    Clin Exp Dermatol; 2000 Jun; 25(4):261-4. PubMed ID: 10971480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contact sensitivity to budesonide in a child.
    Auricchio L; Nino M; Suppa F
    Contact Dermatitis; 2000 Jun; 42(6):359. PubMed ID: 10871107
    [No Abstract]   [Full Text] [Related]  

  • 7. Contact allergy to budesonide and perforation of the nasal septum.
    Isaksson M; Bruze M; Wihl JA
    Contact Dermatitis; 1997 Sep; 37(3):133. PubMed ID: 9330826
    [No Abstract]   [Full Text] [Related]  

  • 8. Contact allergy to inhaled budesonide.
    García AP; Tovar V; de Barrio M; Villanueva A; Tornero P
    Contact Dermatitis; 2008 Jul; 59(1):60-1. PubMed ID: 18598312
    [No Abstract]   [Full Text] [Related]  

  • 9. Contact hypersensitivity to tixocortol pivalate.
    Lutz ME; el-Azhary RA; Gibson LE; Fransway AF
    J Am Acad Dermatol; 1998 May; 38(5 Pt 1):691-5. PubMed ID: 9591812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Systemic effect of nasal corticosteroids?].
    Landerholm L; Mjörndal T
    Lakartidningen; 2006 Oct 18-24; 103(42):3208-9. PubMed ID: 17111993
    [No Abstract]   [Full Text] [Related]  

  • 11. Topical intranasal corticosteroid therapy in rhinitis.
    Siegel SC
    J Allergy Clin Immunol; 1988 May; 81(5 Pt 2):984-91. PubMed ID: 2897390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of long-term intranasal budesonide delivered via the mucosal atomization device for chronic rhinosinusitis.
    Manji J; Singh G; Okpaleke C; Dadgostar A; Al-Asousi F; Amanian A; Macias-Valle L; Finkelstein A; Tacey M; Thamboo A; Javer A
    Int Forum Allergy Rhinol; 2017 May; 7(5):488-493. PubMed ID: 28151588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutaneous-mucosal allergic contact reaction due to topical corticosteroids.
    Gonzalo Garijo MA; Bobadilla González P
    Allergy; 1995 Oct; 50(10):833-6. PubMed ID: 8607567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exhaling a budesonide inhaler through the nose results in a significant reduction in dose requirement of budesonide nasal spray in patients having asthma with rhinitis.
    Shaikh WA
    J Investig Allergol Clin Immunol; 1999; 9(1):45-9. PubMed ID: 10212857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patch testing with budesonide in serial dilutions. A multicentre study of the EECDRG.
    Isaksson M; Andersen KE; Brandão FM; Bruynzeel DP; Bruze M; Diepgen T; Ducomb G; Frosch PJ; Goossens A; Lahti A; Menné T; Seidenari S; Tosti A; Wahlberg J; Wilkinson JD
    Contact Dermatitis; 2000 Jun; 42(6):352-4. PubMed ID: 10871102
    [No Abstract]   [Full Text] [Related]  

  • 16. Patch testing with budesonide.
    Wilkinson SM; Beck MH
    Contact Dermatitis; 1998 Jul; 39(1):52-3. PubMed ID: 9686997
    [No Abstract]   [Full Text] [Related]  

  • 17. Patch testing with budesonide in serial dilutions: the significance of dose, occlusion time and reading time.
    Isaksson M; Bruze M; Goossens A; Lepoittevin JP
    Contact Dermatitis; 1999 Jan; 40(1):24-31. PubMed ID: 9928801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contact allergy to budesonide in a nasal spray.
    Faria A; Marote J; de Freitas C
    Contact Dermatitis; 1992 Jul; 27(1):57. PubMed ID: 1424598
    [No Abstract]   [Full Text] [Related]  

  • 19. Allergic contact dermatitis from 6alpha-methylprednisolone aceponate and budesonide.
    Corazza M; Virgili A
    Contact Dermatitis; 1998 Jun; 38(6):356-7. PubMed ID: 9687052
    [No Abstract]   [Full Text] [Related]  

  • 20. Topical corticosteroid allergy in an urban Australian centre.
    Keegel T; Saunders H; Milne R; Sajjachareonpong P; Fletcher A; Nixon R
    Contact Dermatitis; 2004 Jan; 50(1):6-14. PubMed ID: 15059096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.